QC
UTHR icon

Quent Capital’s United Therapeutics UTHR Stock Holding History

Quent Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
4,104
-19
-0.5% -$10.7K 0.14% 95
2026
Q1 		$2.44M Sell
4,123
-169
-4% -$84.2K 0.17% 71
2025
Q4 		$2.09M Buy
4,292
+3,323
+343% +$1.55M 0.15% 88
2025
Q3 		$406K Buy
969
+5
+0.5% +$1.68K 0.03% 171
2025
Q2 		$277K Sell
964
-14
-1% -$4.18K 0.03% 217
2025
Q1 		$301K Sell
978
-5
-0.5% -$1.71K 0.03% 193
2024
Q4 		$347K Sell
983
-3,232
-77% -$1.19M 0.04% 177
2024
Q3 		$1.51M Buy
4,215
+5
+0.1% +$1.69K 0.15% 82
2024
Q2 		$1.34M Sell
4,210
-7
-0.2% -$1.85K 0.15% 84
2024
Q1 		$969K Sell
4,217
-14
-0.3% -$3.16K 0.11% 106
2023
Q4 		$930K Sell
4,231
-27
-0.6% -$6.22K 0.13% 98
2023
Q3 		$962K Buy
4,258
+38
+0.9% +$8.75K 0.15% 86
2023
Q2 		$932K Sell
4,220
-3
-0.1% -$665 0.15% 83
2023
Q1 		$929K Sell
4,223
-1,962
-32% -$484K 0.16% 83
2022
Q4 		$1.72M Buy
6,185
+22
+0.4% +$5.55K 0.31% 48
2022
Q3 		$1.29M Buy
6,163
+12
+0.2% +$2.68K 0.27% 53
2022
Q2 		$1.45M Sell
6,151
-2,020
-25% -$411K 0.31% 50
2022
Q1 		$1.47M Sell
8,171
-320
-4% -$61K 0.27% 58
2021
Q4 		$1.83M Buy
+8,491
New +$1.67M 0.39% 52

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Quent Capital's UTHR Position: Q2 2026 in Review

Quent Capital reduced its United Therapeutics (UTHR) stake by 0.46% in Q2 2026, selling an estimated $10.7K and leaving 4,104 shares worth $2.22M. The position accounts for 0.14% of the portfolio, ranked #95.

Quent Capital first reported a position in UTHR in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.44M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Quent Capital held 4,104 shares of United Therapeutics worth $2.22M as of Q2 2026.
  • Quent Capital sold 19 United Therapeutics shares in Q2 2026, an estimated $10.7K.
  • United Therapeutics made up 0.14% of Quent Capital's portfolio in Q2 2026, its #95 holding.
  • Quent Capital first reported a position in United Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Quent Capital's United Therapeutics position peaked at $2.44M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.